CRISPR-Cas guides the future of genetic engineering
Open accessThe DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Abstract
The diversity, modularity, and efficacy of CRISPR-Cas systems are driving a biotechnological revolution. RNA-guided Cas enzymes have been adopted as tools to manipulate the genomes of cultured cells, animals, and plants, accelerating the pace of fundamental research and enabling clinical and agricultural breakthroughs. We describe the basic mechanisms that set the CRISPR-Cas toolkit apart from other programmable gene-editing technologies, highlighting the diverse and naturally evolved systems now functionalized as biotechnologies. We discuss the rapidly evolving landscape of CRISPR-Cas applications, from gene editing to transcriptional regulation, imaging, and diagnostics. Continuing functional dissection and an expanding landscape of applications position CRISPR-Cas tools at the cutting edge of nucleic acid manipulation that is rewriting biology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“CRISPR-Cas9 and related enzymes have been used to manipulate the genomes of cultured cells, animals and plants, vastly accelerating the pace of fundamental research and enabling breakthroughs in agriculture and synthetic biology (reviewed in refs. 6-9).”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [6]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Self-citationMultiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
CRISPR Provides Acquired Resistance Against Viruses in Prokaryotes
Barrangou, R., Fremaux, C., Deveau, H., Richards, M., Boyaval, P., Moineau, S., Romero, D. A., & Horvath, P. (2007) · Science · doi:10.1126/science.1138140 · Cited by 5,947
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A., & Liu, D. R. (2016) · Nature · doi:10.1038/nature17946 · Cited by 5,437
Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System
Zetsche, B., Gootenberg, J. S., Abudayyeh, O. O., Slaymaker, I. M., Makarova, K. S., Essletzbichler, P., Volz, S. E., Joung, J., van der Oost, J., Regev, A., et al. (2015) · Cell · doi:10.1016/j.cell.2015.09.038 · Cited by 4,761
CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity
Chen, J. S., Ma, E., Harrington, L. B., Da Costa, M., Tian, X., Palefsky, J. M., & Doudna, J. A. (2018) · Science · doi:10.1126/science.aar6245 · Cited by 4,507
Self-citationProgrammable base editing of A•T to G•C in genomic DNA without DNA cleavage
Gaudelli, N. M., Komor, A. C., Rees, H. A., Packer, M. S., Badran, A. H., Bryson, D. I., & Liu, D. R. (2017) · Nature · doi:10.1038/nature24644 · Cited by 4,184
Nucleic acid detection with CRISPR-Cas13a/C2c2
Gootenberg, J. S., Abudayyeh, O. O., Lee, J. W., Essletzbichler, P., Dy, A. J., Joung, J., Verdine, V., Donghia, N., Daringer, N. M., Freije, C. A., et al. (2017) · Science · doi:10.1126/science.aam9321 · Cited by 3,844
In vivo genome editing using Staphylococcus aureus Cas9
Ran, F. A., Cong, L., Yan, W. X., Scott, D. A., Gootenberg, J. S., Kriz, A. J., Zetsche, B., Shalem, O., Wu, X., Makarova, K. S., et al. (2015) · Nature · doi:10.1038/nature14299 · Cited by 2,687
Research works printed but not linked: 3
- 47. Rousseau BA, Hou Z, Gramelspacher MJ, Zhang Y, Mol. Cell (2018), doi:10.1016/j.molcel. 2018.01.025. · doi:10.1016/j.molcel
- 63. Chen JS, Ma E, Harrington LB, Tian X, Doudna JA, bioRxiv, 226993 (2017).
- 71. Charlesworth CT et al., bioRxiv, 243345 (2018).
Cited by
Items 601–700 of 1,000
Ma, S., Li, Y., Liu, F., Wang, X., Qin, Z., Wang, L., Yang, J. P., Wang, L., Yang, W., Wang, N., et al. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.01.001 · Cited by 19
CRISPR/Cas9 as a Mutagenic Factor
Shumega, A. R., Pavlov, Y. I., Chirinskaite, A. V., Rubel, A. A., Inge-Vechtomov, S. G., & Stepchenkova, E. I. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020823 · Cited by 18
“…defective genes in various of cell types (including human embryonic and stem cells) [9,10]; in the discovery of new drug targets [11]; in pathogen diagnostics [12]; in genetic modification of plants to enhance crop yields, disease resistance, and reduce pesticide use [13]; and in other areas.”
BackgroundFieni, C., Sorrentino, C., Ciummo, S. L., Fontana, A., Lotti, L. V., Scialis, E. S., Garcia, D. C., Caulo, M., & Carlo, E. D. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-024-01310-2 · Cited by 19
“CRISPR/Cas9 is the most developed and widely used tool for current genome editing strategies 13 , because it is highly speci fi c, ef fi cient, and versatile 14 , and has entered clinical trials for the treatment of different human diseases, such as hematological disorders, cancer, inherited eye…”
MethodDNA Nanocarriers for Delivery of sgRNA/Cas9 Ribonucleoprotein
Zhu, H., Fan, J., Yang, C., Liu, J., & Ding, B. (2024) · Nano Biomedicine and Engineering · doi:10.26599/nbe.2024.9290096 · Cited by 18
Oxidative DNA Cleavage with Clip‐Phenanthroline Triplex‐Forming Oligonucleotide Hybrids
Panattoni, A., El-Sagheer, A. H., Brown, T., Kellett, A., & Hocek, M. (2019) · ChemBioChem · doi:10.1002/cbic.201900670 · Cited by 19
Use of Customizable Nucleases for Gene Editing and Other Novel Applications
Reddy, P., Vilella, F., Belmonte, J. C. I., & Simón, C. (2020) · Genes · doi:10.3390/genes11090976 · Cited by 18
“The CRISPR-Cas9 has been widely used for genetic modification in several different organisms, including plants [31,32].”
BackgroundMethodTian, K. V., Guo, Y., Zou, B., Wang, L., Zhang, Y., Qi, Z., Zhou, J., Wang, X., Zhou, G., Wei, L., et al. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa843 · Cited by 19
CRISPR/Cas correction of muscular dystrophies
Zhang, Y., Nishiyama, T., Olson, E. N., & Bassel‐Duby, R. (2021) · Experimental Cell Research · doi:10.1016/j.yexcr.2021.112844 · Cited by 22
Kirillov, B., Savitskaya, E. E., Panov, M., Ogurtsov, A. Y., Shabalina, S. A., Koonin, E. V., & Severinov, K. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab1065 · Cited by 22
“The parameter input shape in the model definition is changed to (4, 23, 2).”
Zhai, Y.-L., Dong, S., Zou, M., Qin, Y.-D., Liu, L., Cao, M.-H., Huang, M., Vasseur, L., You, M., & Peng, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179538 · Cited by 18
“Considering that an effective RNAi is difficult to obtain in most lepidopteran insects [33], the technology of CRISPR/Cas9 (clustered regularly interspaced short palindromic repeat/CRISPR-associated nuclease 9) can be effective to explore the gene functions in vivo [34,35].”
BackgroundImplications of scar structure and mechanics for post-infarction cardiac repair and regeneration
French, B. A., & Holmes, J. W. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.01.001 · Cited by 18
The Expanding Class 2 CRISPR Toolbox: Diversity, Applicability, and Targeting Drawbacks
Dastjerdi, A. H., Newman, A., & Burgio, G. (2019) · BioDrugs · doi:10.1007/s40259-019-00369-y · Cited by 18
Sinnige, T., Stroobants, K., Dobson, C. M., & Vendruscolo, M. (2020) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583520000025 · Cited by 22
“The creation of specific animal models is becoming technically more feasible with developments in geneticengineering techniques such as CRISPR/Cas9 (Knott and Doudna, 2018; Zhang, 2019), and by introducing additional genetic or environmental perturbations the need for the artificially high…”
MethodPAM-adjacent DNA flexibility tunes CRISPR-Cas12a off-target binding
Allen, A., Cooper, B. H., Singh, J. K., Rohs, R., & Qin, P. Z. (2025) · Scientific Reports · doi:10.1038/s41598-025-87565-9 · Cited by 19
Noormohamadi, H., Samarkhazan, H. S., Kargar, M., Maroufi, F., Servatian, N., & Davami, F. (2025) · Discover Oncology · doi:10.1007/s12672-025-03383-5 · Cited by 17
Zhao, C., Wang, Y., Nie, X., Han, X., Liu, H., Li, G., Yang, G., Ruan, J., Ma, Y., Li, X., et al. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.37152 · Cited by 18
“This method is faster, cheaper, more accurate, and more efficient than traditional genome editing technology and has a wide range of potential applications [6].”
MethodAhangar, M. A., Wani, S. H., Dar, Z. A., Jan, R., Mohiddin, F. A., Bansal, M., Choudhary, M., Aggarwal, S. K., Waza, S. A., Dar, K. A., et al. (2022) · Phyton · doi:10.32604/phyton.2022.020721 · Cited by 22
DNA-functionalized colloidal crystals for macromolecular encapsulation
Yokomori, M., Suzuki, H., Nakamura, A., Sugano, S. S., & Tagawa, M. (2022) · Soft Matter · doi:10.1039/d2sm00949h · Cited by 17
Nguyen, N. T. K., Tu, Y., Lee, H.-S., Truong, V. A., Chang, Y., Pham, N. N., Chang, C.-W., Lin, Y.-H., Lai, P.-L., Chen, P., et al. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122106 · Cited by 19
Rao, Y., Wang, J., Yang, X., Xie, X., Zhan, Y., Ma, X., Cai, D., & Chen, S. (2023) · Metabolic Engineering · doi:10.1016/j.ymben.2023.06.004 · Cited by 18
Fusing Allosteric Ribozymes with CRISPR‐Cas12a for Efficient Diagnostics of Small Molecule Targets
Guo, L., Zhang, S., Du, X., Zhou, M., & Gu, H. (2024) · Small Methods · doi:10.1002/smtd.202401236 · Cited by 17
State-of-the-art signal amplification strategies for nucleic acid and non-nucleic acid biosensors
Gul, I., Raheem, M. A., Reyad‐ul‐Ferdous, M., Yuan, X., Chen, Z., lv, C., Chen, M., Ji, J., Wu, D., Zhao, Q., et al. (2024) · Sensors and Actuators Reports · doi:10.1016/j.snr.2024.100268 · Cited by 17
A CRISPR/Cas12a-Assisted SERS Nanosensor for Highly Sensitive Detection of HPV DNA
Ye, J., Shen, Y., Lin, Z., Xu, L., Wang, L., Lin, X., Huang, B., Ma, Z., Yu, Z., Lin, D., et al. (2025) · ACS Sensors · doi:10.1021/acssensors.5c00547 · Cited by 22
Delivery of genome editing tools by bacterial extracellular vesicles
Liu, Y., Smid, E. J., Abee, T., & Notebaart, R. A. (2018) · Microbial Biotechnology · doi:10.1111/1751-7915.13356 · Cited by 17
Kissling, L., Monfort, A., Swarts, D. C., Wutz, A., & Jínek, M. (2019) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2018.10.028 · Cited by 18
Precise editing of plant genomes – Prospects and challenges
Satheesh, V., Zhang, H., Wang, X., & Lei, M. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.04.010 · Cited by 22
Technical advances contribute to the study of genomic imprinting
Li, Y., & Li, J. (2019) · PLoS Genetics · doi:10.1371/journal.pgen.1008151 · Cited by 18
Temblador, A., Topalis, D., Andreï, G., & Snoeck, R. (2019) · Cancers · doi:10.3390/cancers11091260 · Cited by 18
“In recent years, the CRISPR/Cas9 system has revolutionized the genome-engineering field [23].”
BackgroundIn silico Method in CRISPR/Cas System: An Expedite and Powerful Booster
Zhang, Y., Zhao, G., Ahmed, F. Y. H., Yi, T., Hu, S., Cai, T., & Liao, Q. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.584404 · Cited by 20
“The state-of-the-art CRISPR/Cas system for genetic manipulation is an emerging tool to solve this nerve-wracking problem (2).”
BackgroundAshok, K. R., Bhargava, C. N., Karakatti, P. B., Wishard, R., Manamohan, M., Rai, A. K., Pradhan, S. K., Parvathy, M. S., Kennedy, J. S., & Asokan, R. (2022) · Journal of Asia-Pacific Entomology · doi:10.1016/j.aspen.2022.102031 · Cited by 20
Recommendations for Advancing Genome to Phenome Research in Non-Model Organisms
Burnett, K. G., Durica, D. S., Mykles, D. L., Stillman, J. H., & Schmidt, C. J. (2020) · Integrative and Comparative Biology · doi:10.1093/icb/icaa059 · Cited by 17
Off-target effects and the solution
Tang, J., Chen, L., & Liu, Y. (2019) · Nature Plants · doi:10.1038/s41477-019-0406-z · Cited by 17
Zhang, W., Feng, Z., Feng, Z., Lian, R., Liu, Z., & Zhang, J. (2025) · ACS Nano · doi:10.1021/acsnano.5c12641 · Cited by 16
Powdery Mildew of Wheat: Research Progress, Opportunities, and Challenges
Rana, V., Batheja, A., Sharma, R., Rana, A. S., & Priyanka (2022) · Springer eBooks · doi:10.1007/978-981-16-4134-3_5 · Cited by 19
The Dawn of In Vivo Gene Editing Era: A Revolution in the Making
Niazi, S. K. (2023) · Biologics · doi:10.3390/biologics3040014 · Cited by 23
CRISPR-Cas14a with competitive isothermal amplification for rapid visual pathogen diagnosis
Meng, T., Ren, Y., Wang, Q., Lin, L., Luo, Y., Zhang, J., Zhang, Q. Y., Dzantiev, B. B., Negahdary, M., Wan, Y., et al. (2023) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2023.134946 · Cited by 16
Powdery Mildew of Bigleaf Hydrangea: Biology, Control, and Breeding Strategies for Resistance
Jennings, C., Baysal-Gurel, F., & Alexander, L. W. (2024) · Horticulturae · doi:10.3390/horticulturae10030216 · Cited by 16
The immune system of prokaryotes: potential applications and implications for gene editing
Liu, S. M., Liu, H., Wang, X., & Shi, L. (2024) · Biotechnology Journal · doi:10.1002/biot.202300352 · Cited by 19
A Sensitive Technique Unravels the Kinetics of Activation and Trans ‐Cleavage of CRISPR‐Cas Systems
Feng, W., Peng, H., Zhang, H., Weinfeld, M., & Le, X. C. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202404069 · Cited by 16
Feng, X., Xu, R., Liao, J., Zhao, J., Zhang, B., Xu, X., Zhao, P., Wang, X., Yao, J., Wang, P., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47697-4 · Cited by 20
“The DNA fragment was directly ampli fi ed from the E233 genome using the primers tnpB7-F-NdeI and tnpB7-R-NheI as indicated in Supplementary Data 1.”
InfluentialCRISPR-Cas Systems: A Functional Perspective and Innovations
Navarro, C., Diaz, M. P., Durán, P., Castro, A., Díaz, A., Cano, C., Carbonell, A., Solano-Jimenez, D.-S., Rivera-Porras, D., Contreras-Velásquez, J., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083645 · Cited by 19
“…associated with the delivery of the gene-editing machinery and the precise genome cost, e ff ectiveness, access to this resource, and the need to create regulating legislation [8– fuels the hope that in the future, genome editing through the CRISPR-Cas system is expected to be a fi rst-line 11].”
CRISPR-Cas12a Nucleases Bind Flexible DNA Duplexes without RNA/DNA Complementarity
Jiang, W., Singh, J. K., Allen, A., Li, Y., Kathiresan, V., Qureshi, O. A., Tangprasertchai, N. S., Zhang, X., Parameshwaran, H. P., Rajan, R., et al. (2019) · ACS Omega · doi:10.1021/acsomega.9b01469 · Cited by 17
Goshayeshi, L., Taemeh, S. Y., Dehdilani, N., Nasiri, M., Seno, M. M. G., & Dehghani, H. (2021) · The FASEB Journal · doi:10.1096/fj.202001830rr · Cited by 16
Kell, D. B. (2021) · Advances in microbial physiology/Advances in Microbial Physiology · doi:10.1016/bs.ampbs.2021.01.001 · Cited by 16
In Vitro Evaluation of a Nanoparticle-Based mRNA Delivery System for Cells in the Joint
Sturm, L., Faustini, B., Menzel, U., Häckel, S., Albers, C. E., Plank, C., Rip, J., Alini, M., Traweger, A., Grad, S., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9070794 · Cited by 18
“The more recent introduction of the CRISPR/Cas technology, where a specific gene can be targeted, modified, turned on/off, has propelled gene therapy into a new era but still results in permanent integration into the genome [23,24].”
BackgroundCRISPR Technique Incorporated with Single-Cell RNA Sequencing for Studying Hepatitis B Infection
Le, C., Liu, Y., López-Orozco, J., Joyce, M., Le, X. C., & Tyrrell, D. L. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.1c02227 · Cited by 17
Zhang, Q., Chen, Z., Wang, F., Zhang, S., Chen, H., Gu, X., Wen, F., Jin, J., Zhang, X., Huang, X., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab1139 · Cited by 16
“Owing to the simplicity and specificity of programmable DNA recognition and cleavage by these complexes, Cas9/sgRNA systems have proven to be extremely versatile tools for genome engineering applications (5).”
Bauersachs, H. G., Bengtson, C. P., Weiss, U. K., Hellwig, A., Vilela, C. G., Zaremba, B., Kaessmann, H., Pruunsild, P., & Bading, H. (2021) · Neuroscience · doi:10.1016/j.neuroscience.2021.12.026 · Cited by 17
Liu, Q., Liu, M., Jin, Y., & Li, B. (2022) · The Analyst · doi:10.1039/d2an00613h · Cited by 16
BEtarget: A versatile web-based tool to design guide RNAs for base editing in plants
Xie, X., Li, F., Tan, X., Zeng, D., Liu, W., Zeng, W., Zhu, Q., & Liu, Y. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.07.046 · Cited by 16
“In most eukaryotes, DSB is predominantly repaired by the error-prone non-homologous end joining (NHEJ) pathway, generally resulting in random nucleotide insertion or deletion mutations [9,10].”
BackgroundAn FGFR1-Binding Peptide Modified Liposome for siRNA Delivery in Lung Cancer
Dong, Z., Yin, Y., Luo, J., Li, B., Lou, F., Wang, Q., Zhou, Q., Ye, B., & Wang, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158380 · Cited by 17
“With the development of genetic engineering [1], cell engineering [2], and protein engineering [3], molecular biology has shown a leading position in life science [4].”
BackgroundEngineering CRISPR/Cas-based nanosystems for therapeutics, diagnosis and bioimaging
Song, N., Li, S., Lv, Z., Ding, X., Li, F., & Yang, D. (2023) · Chinese Chemical Letters · doi:10.1016/j.cclet.2023.108134 · Cited by 16
Li, Y., Zhao, W. H., Wu, Y., Li, R., Zhang, J., Xie, H., Zhang, K., & Li, J. (2025) · Chemical Society Reviews · doi:10.1039/d5cs00921a · Cited by 18
Exploring the dynamic nature of divalent metal ions involved in DNA cleavage by CRISPR–Cas12a
Son, H., Park, J.-I., Choi, Y. H., Jung, Y., Lee, J.-W., Bae, S., & Lee, S.-H. (2022) · Chemical Communications · doi:10.1039/d1cc04446j · Cited by 16
Molecular basis of dual anti-CRISPR and auto-regulatory functions of AcrIF24
Kim, G. E., Lee, S. Y., Birkholz, N., Kamata, K., Jeong, J., Kim, Y., Fineran, P. C., & Park, H. H. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac880 · Cited by 15
Nakamura, A., Yano, T., Mitsuda, N., Furubayashi, M., Ito, S., Sugano, S. S., & Terakawa, T. (2023) · Scientific Reports · doi:10.1038/s41598-023-40433-w · Cited by 16
CRISPR/Cas9 mutagenesis of the Arabidopsis GROWTH-REGULATING FACTOR (GRF) gene family
Angulo, J., Astin, C. P., Bauer, O., Blash, K. J., Bowen, N. M., Chukwudinma, N. J., DiNofrio, A. S., Faletti, D. O., Ghulam, A. M., Gusinde-Duffy, C. M., et al. (2023) · Frontiers in Genome Editing · doi:10.3389/fgeed.2023.1251557 · Cited by 16
“…bind virtually any DNA sequence, enabling applications as diverse as chemical modi fi cation of target DNA, directed manipulation of gene transcription, or genome editing by homologous recombination (reviewed in Knott and Doudna, 2019; Soyars et al., 2018; Manghwar et al., 2019; Zhang et al., 2019).”
BackgroundPredicting CRISPR-Cas12a guide efficiency for targeting using machine learning
O’Brien, A. R., Bauer, D. C., & Burgio, G. (2023) · PLoS ONE · doi:10.1371/journal.pone.0292924 · Cited by 18
Wang, L., Liu, J., Tang, J., Dang, Y., Sun, L., Liu, B., Li, H., He, X., Shuai, Q., Peng, Z., et al. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.135339 · Cited by 18
Engineering biotic stress tolerance via CRISPR-Cas mediated genome editing in crop plants
Hussain, A., Munir, M., Khalid, A., Ali, M., Amanullah, M., Ali, Q., & Manghwar, H. (2024) · Plant Stress · doi:10.1016/j.stress.2024.100650 · Cited by 16
Zha, C.-J., Zhang, H., he, S. T., Zhao, N., He, L., Yang, N., & Ying, Z. (2025) · Talanta · doi:10.1016/j.talanta.2025.128049 · Cited by 16
Innovative Chemical Strategies for Advanced CRISPR Modulation
Liu, X., Zhou, E., Qi, Q., Xiong, W., Tian, T., & Zhou, X. (2025) · Accounts of Chemical Research · doi:10.1021/acs.accounts.5c00052 · Cited by 17
Huang, Z., Zhu, J., Bu, X., Lu, S., Luo, Y., Liu, T., Duan, N., Wang, W., Wang, Y., & Wang, X. (2025) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00688-9 · Cited by 18
Erratic journey of CRISPR/Cas9 in oncology from bench-work to successful-clinical therapy
Sarkar, E., & Khan, A. A. (2021) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2020.100289 · Cited by 18
Simultaneous gene editing of three homoeoalleles in self‐incompatible allohexaploid grasses
Zhang, L. N., Wang, T., Wang, G., Bi, A., Wassie, M., Xie, Y., Cao, L., Xu, H., Fu, J., Chen, L., et al. (2021) · Journal of Integrative Plant Biology · doi:10.1111/jipb.13101 · Cited by 15
“CRISPR/Cas12a (Cpf1) was characterized as a new type V, © 2021 Institute of Botany, Chinese Academy of Sciences class 2 system CRISPR effector (Knott and Doudna, 2018).”
BackgroundTargeting angiopoietin‐like 3 in atherosclerosis: From bench to bedside
Ling, P., Zheng, X., Luo, S., Ge, J., Xu, S., & Weng, J. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14450 · Cited by 16
“Clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 technology is a widely used gene editing tool, renowned for its ability to introduce specific mutations at a desired location in the genome.(104,105) With Base Editor 3 (BE3), a modified CRISPR-Cas9 platform, Chadwick et al.”
MethodRETRACTED: Precise editing of FGFR3-TACC3 fusion genes with CRISPR-Cas13a in glioblastoma
Wu, Y., Jin, W., Wang, Q., Zhou, J., Wang, Y., Tan, Y., Cui, X., Tong, F., Yang, E., Wang, J., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.07.002 · Cited by 15
RetractedLoss of MAR1 Function is a Marker for Co-Selection of CRISPR-Induced Mutations in Plants
Rinne, J., Witte, C., & Herde, M. (2021) · Frontiers in Genome Editing · doi:10.3389/fgeed.2021.723384 · Cited by 15
“Originally adapted from a bacterial pathogen defense system, it is now one of the major biotechnological methods in the field of plant science with diverse applications ranging from fundamental research to crop optimization (Jaganathan et al., 2018; Knott and Doudna, 2018; Afzal et al., 2020; Zhu et al., 2020).”
BackgroundRueda, J. (2021) · Theoria · doi:10.1111/theo.12349 · Cited by 15
“The diversity, modularity, and efficacy of the CRISPR-Cas9 toolkit enable enormous clinical and agricultural breakthroughs, making it the leader of the future of precision genome engineering (Knott and Doudna, 2018).”
BackgroundFuture Perspectives of Oral Delivery of Next Generation Therapies for Treatment of Skin Diseases
Søgaard, P. P., Lind, M. L., Christiansen, C. R., Petersson, K., Clauss, A., & Caffarel–Salvador, E. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13101722 · Cited by 15
“CRISPR-Cas9 mediated gene editing builds on the principle of having a nuclease capable of creating double strand breaks (DSBs) being targeted to a specific sequence in the genome by forming a complex with a guide RNA (gRNA) [22].”
BackgroundTang, N., Ning, Q., Wang, Z., Tao, Y., Zhao, X., & Tang, S. (2021) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2021.112257 · Cited by 15
Molecular Biological Aspects of Depressive Disorders: A Modern View
Ushakova, V. M., Morozova, A. Y., Reznik, A. M., Kostyuk, G. P., & Chekhonin, V. P. (2020) · Molecular Biology · doi:10.1134/s0026893320050118 · Cited by 17
CRISPR-Cas Detection Coupled with Isothermal Amplification of Bursaphelenchus xylophilus
Tang, C., Wu, J. C., Chen, Q., & Wang, Y. (2022) · Plant Disease · doi:10.1094/pdis-07-22-1648-sr · Cited by 15
Filamentous‐Actin‐Mimicking Nanoplatform for Enhanced Cytosolic Protein Delivery
Xia, Y., Wu, K., Liu, C., Zhao, X., Wang, J., Cao, J., Chen, Z., Fang, M., Yu, J., Zhu, C., et al. (2023) · Advanced Science · doi:10.1002/advs.202305600 · Cited by 19
Munir, M., Embry, A., Doench, J. G., Heaton, N. S., Wilen, C. B., & Orchard, R. C. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107153 · Cited by 15
“While most screens have focused on loss-of-function phenotypes, modi fi cations to the CRISPR/Cas9 system enable gain-of-function screening through the transactivation of gene expression (9).”
CRISPR-Cas System for RNA Detection and Imaging
Chen, S., Wang, R., Lei, C., & Nie, Z. (2019) · Chemical Research in Chinese Universities · doi:10.1007/s40242-019-0030-5 · Cited by 15
Nucleolar stress in Drosophila neuroblasts, a model for human ribosomopathies
Baral, S. S., Lieux, M. E., & DiMario, P. J. (2020) · Biology Open · doi:10.1242/bio.046565 · Cited by 19
Trogu, S., Ermert, A. L., Stahl, F., Nogué, F., Gans, T., & Hughes, J. (2020) · Plant Molecular Biology · doi:10.1007/s11103-020-01103-x · Cited by 15
Developing Practical Therapeutic Strategies that Target Protein SUMOylation
Cox, O. F., & Huber, P. W. (2018) · Current Drug Targets · doi:10.2174/1389450119666181026151802 · Cited by 15
Hou, Z., & Zhang, Y. (2019) · Science · doi:10.1126/science.aay2056 · Cited by 15
Sinnige, T., Stroobants, K., Dobson, C. M., & Vendruscolo, M. (2020) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583520000104 · Cited by 17
Mehnath, S. (2025) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgaf127 · Cited by 15
Nanoparticle-based non-viral CRISPR delivery for enhanced immunotherapy
Shin, H., & Kim, J. (2022) · Chemical Communications · doi:10.1039/d1cc05999h · Cited by 14
Enhanced sampling strategies for molecular simulation of DNA
Mohr, B., van Heesch, T., Ortíz, A. P. D. A., & Vreede, J. (2024) · Wiley Interdisciplinary Reviews Computational Molecular Science · doi:10.1002/wcms.1712 · Cited by 14
“36,37 As an example system to illustrate enhanced sampling strategies for protein – DNA complexes, we will focus on the DNA binding domain (DBD) of the Histone-like nucleoid structuring protein (H-NS), see Figure 1b. H-NS is a bacterial DNA-binding protein involved in DNA organization.”
BackgroundMa, Y., Tan, Y., Li, J., Xiang, Q., Liu, S., Jin, X., Shao, S., Geng, W., Zhu, L., & Yang, D. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.4c03206 · Cited by 14
Sobral, A. F., Dinis‐Oliveira, R. J., & Barbosa, D. J. (2024) · Forensic Science International Genetics · doi:10.1016/j.fsigen.2024.103163 · Cited by 17
Mehmood, A., Ali, W., Din, Z. U., Song, S., Sohail, M., Shah, W., Guo, J., Guo, R., Ilahi, I., Shah, S., et al. (2021) · Brain and Behavior · doi:10.1002/brb3.2280 · Cited by 18
“CRISPR/Cas9 genome editing technology has already been used to research and therapy various disorders such as various monogenic diseases, cancer, central nervous system (CNS) diseases, and AIDS (Knott & Doudna, 2018).”
BackgroundJiang, L., Zeng, W., Wu, W., Deng, Y., He, F., Liang, W., Huang, M., Huang, H., Li, Y., Wang, X., et al. (2021) · Emerging infectious diseases · doi:10.3201/eid2709.200091 · Cited by 14
Molecular Manipulations and Intestinal Stem Cell-Derived Organoids in Inflammatory Bowel Disease
Boye, T. L., Steenholdt, C., Jensen, K. B., & Nielsen, O. H. (2022) · Stem Cells · doi:10.1093/stmcls/sxac014 · Cited by 14
Li, H., Yang, J., Wu, G., Weng, Z., Song, Y., Zhang, Y., Vanegas, J. A., Avery, L., Gao, Z. J., Sun, H., et al. (2022) · Angewandte Chemie · doi:10.1002/ange.202203826 · Cited by 57
Li, S., Fangfang, W., Wang, C., Wang, Z., & Wu, Q. (2022) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2022.132848 · Cited by 18
Engineered ATG8‐binding motif‐based selective autophagy to degrade proteins and organelles in planta
Luo, N., Shang, D., Tang, Z., Mai, J., Huang, X., Tao, L., Liu, L., Gao, C., Qian, Y., Xie, Q., et al. (2022) · New Phytologist · doi:10.1111/nph.18557 · Cited by 14
Ren, D., Chen, Q., Xia, X., Xu, G., Wei, F., Yang, J., Hu, Q., & Cen, Y. (2023) · Analytica Chimica Acta · doi:10.1016/j.aca.2023.341750 · Cited by 14
Richardson, R. R., Steyert, M. R., Khim, S. N., Crutcher, G. W., Brandenburg, C., Robertson, C. D., Romanowski, A. J., Inen, J., Altas, B., & Poulopoulos, A. (2023) · The CRISPR Journal · doi:10.1089/crispr.2023.0036 · Cited by 14
Srinivas, S., Hu, Z., & Cronan, J. E. (2019) · Plasmid · doi:10.1016/j.plasmid.2019.04.004 · Cited by 14
“An important recent breakthrough has been the development of a novel RNA-guided endonuclease-based genome editing system called the clustered regularly interspaced short palindromic repeat (CRISPR) (Knott and Doudna, 2018).”
BackgroundGermline Genome Editing Research: What Are Gamete Donors (Not) Informed About in Consent Forms?
Niemiec, E., & Howard, H. C. (2020) · The CRISPR Journal · doi:10.1089/crispr.2019.0043 · Cited by 15
Regulation of Microbial Metabolic Rates Using CRISPR Interference With Expanded PAM Sequences
Kim, B.-J., Kim, H. J., & Lee, S. J. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00282 · Cited by 14
“…genome editing can be achieved by the introduction of single-stranded oligonucleotides and/or double-stranded DNA fragments flanking homologous regions into prokaryotic or eukaryotic cells, respectively, which can be negatively selected by the CRISPR/Cas9 nuclease (Knott and Doudna, 2018).”
BackgroundWang, Q., Chear, S., Wing, K., Stellon, D., Tran, M. T. N., Talbot, J., Pébay, A., Hewitt, A. W., & Cook, A. L. (2021) · Methods · doi:10.1016/j.ymeth.2021.02.009 · Cited by 15
Antisense RNA Design, Delivery, and Analysis
Arechavala‐Gomeza, V., & Garanto, A. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2010-6 · Cited by 16
Recent progress of Bioinspired Hydrogel-based delivery system for endometrial repair
Dong, R., Ma, S., Zhao, X., Wang, B., Roy, M., Lü, Y., Xia, T. D., & Liu, Y. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1013217 · Cited by 14
“The system contains a complex of the guide RNA (gRNA) that recognizes its complementary target DNA and the Cas nuclease that cut the dsDNA (Knott and Doudna, 2018; Es et al., 2019).”
Background
Metadata
- Authors
- Knott, G. J., & Doudna, J. A.
- Affiliations
- University of California, Berkeley (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Doudna, Jennifer A.
- Venue
- Science
- Published
- 2018-08-31
- Volume
- 361
- Issue
- 6405
- Pages
- 866-869
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC6455913
- OpenAlex
- W2888908334
- Cited by
- 1,410
- References
- 76
- Citations by year
- 2026: 92 · 2025: 155 · 2024: 169 · 2023: 177 · 2022: 214 · 2021: 223 · 2020: 205 · 2019: 149 · 2018: 23
- FWCI
- 14.76
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Keywords
- CRISPR-Cas, genome editing, transcriptional regulation, CRISPR-Cas diagnostics, agricultural biotechnology
- MeSH terms
- Gene Editing, CRISPR-Associated Protein 9, RNA, Guide, CRISPR-Cas Systems, Animals, Bacterial Proteins, DNA, Endonucleases, Genetic Engineering, Humans, Plants, RNA, Transcription, Genetic, Molecular Imaging, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.